(Q43590182)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Antagonism at 5-HT(2A) receptors potentiates the effect of haloperidol in a conditioned avoidance response task in rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

M G Wadenberg

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

J L Browning

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P B Hicks

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

Pharmacology, Biochemistry and Behavior

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

363-370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: a comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Positron emission tomographic analysis of dose-dependent MDL 100,907 binding to 5-hydroxytryptamine-2A receptors in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Differential effects of amphetamine and neuroleptics on negative vs. positive symptoms in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Pharmacological Specificity of Conditioned Avoidance Response Inhibition in Rats: Inhibition by Neuroleptics and Correlation to Dopamine Receptor Blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

8-OH-DPAT, a 5-HT1A agonist and ritanserin, a 5-HT2A/C antagonist, reverse haloperidol-induced catalepsy in rats independently of striatal dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

The current status of the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Risperidone in the treatment of negative symptoms of schizophrenia: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Ritanserin, a selective 5-HT2/1C antagonist, and negative symptoms in schizophrenia. A placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Amperozide and conditioned behaviour in rats: potentiation by classical neuroleptics and alpha-methylparatyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

The Paw test: an animal model for neuroleptic drugs which fulfils the criteria for pharmacological isomorphism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

The Role of Serotonin Receptor Subtypes in the Behavioural Effects of Neuroleptic Drugs. A Paw Test Study in Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Behavioural effects of serotonin agonists and antagonists in the rat and marmoset.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

5-HT2 antagonism and EPS benefits: is there a causal connection?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Effects of mianserin in neuroleptic-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Selective visualization of rat brain 5-HT2A receptors by autoradiography with [3H]MDL 100,907.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

[3H]MDL 100,907 labels 5-HT2A serotonin receptors selectively in primate brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

From motivation to action: functional interface between the limbic system and the motor system.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Effects of dopamine antagonists in a two-way active avoidance procedure in rats: interactions with 8-OH-DPAT, ritanserin, and prazosin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Attenuation of haloperidol-induced catalepsy by a 5-HT2C receptor antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

The role of 5-HT2A receptors in antipsychotic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Antagonism by 8-OH-DPAT, but not ritanserin, of catalepsy induced by SCH 23390 in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Suppression of conditioned avoidance behavior by the local application of (-)sulpiride into the ventral, but not the dorsal, striatum of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Enhancement of antipsychotic-like properties of the dopamine D2 receptor antagonist, raclopride, by the additional treatment with the 5-HT2 receptor blocking agent, ritanserin, in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Enhancement of antipsychoticlike properties of raclopride in rats using the selective serotonin2A receptor antagonist MDL 100,907.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

A novel computer-controlled conditioned avoidance apparatus for rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

The in vivo effects of olanzapine and other antipsychotic agents on receptor occupancy and antagonism of dopamine D1, D2, D3, 5HT2A and muscarinic receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2800%2900483-4

7 January 2021

10.1016/S0091-3057(00)00483-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11325387%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference